1997 Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

Volume 1, 1997 Archive
Six back issues from 1997 on one convenient archive.

Permanent storage and easy retrieval of IJPC articles and formulations.

Print journal articles in color from the PDF file for your marketing needs.
Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00

(Select Format)

This archive contains the following articles listed by volume, issue and page number:


Issues Included
Volume/Issue	Date	Title
Vol. 1 No. 1	January/February 1997	Hospice Care
Vol. 1 No. 2	March/April 1997	Pediatric Care
Vol. 1 No. 3	May/June 1997	Geriatric Care
Vol. 1 No. 4	July/August 1997	Compounding for Animals
Vol. 1 No. 5	September/October 1997	Home Health Care
Vol. 1 No. 6	November/December 1997	Diverse Ambulatory Patients

Volume 1, 1997 Articles

Title (Click for Details)	Vol/Issue	Page

Volume 1, 1997 Articles
Hospice Care and the Pharmacist	Vol. 1 No. 1	11
Rectal and Stomal Administration of Analgesic Suppositories	Vol. 1 No. 1	12
Omeprazole (Prilosec) in the Atypical Patient, Administration of	Vol. 1 No. 1	13
The Ten Basic Steps in Filling a Prescription: Then and Now	Vol. 1 No. 1	14
Aromatherapy and the Hospice Patient	Vol. 1 No. 1	18
Aromatherapy Mood Elevation No. 1	Vol. 1 No. 1	20
Aromatherapy Mood Elevation No. 2	Vol. 1 No. 1	21
An Ancient Heritage Beckons Pharmacists	Vol. 1 No. 1	22
ABH Hard Troche	Vol. 1 No. 1	26
ABH Soft Troche	Vol. 1 No. 1	27
ABH Sugar Troche	Vol. 1 No. 1	27
Antiemetic Suppositories of the Gralla Type	Vol. 1 No. 1	28
HDDM Hard Troche	Vol. 1 No. 1	29
HDDM Soft Troche	Vol. 1 No. 1	30
HDDM Sugar Troche	Vol. 1 No. 1	30
Metoclophen Nausea Suppositories	Vol. 1 No. 1	31
Metoclophen-Modified Nausea Suppositories	Vol. 1 No. 1	31
Morphine Sulfate Slow-Release Suppositories	Vol. 1 No. 1	32
Ondansetron HCl Suppositories	Vol. 1 No. 1	34
Morphine Suppositories	Vol. 1 No. 1	36
Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution	Vol. 1 No. 1	37
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel	Vol. 1 No. 1	38
Suppository Displacement Factor	Vol. 1 No. 1	39
Rule of Sixes for Filling Hard-Shell Gelatin Capsules	Vol. 1 No. 1	40
Electronic Balance Maintenance/Calibration	Vol. 1 No. 1	45
General Guidelines for Use of Chemicals for Prescription Compounding	Vol. 1 No. 1	46
Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion	Vol. 1 No. 1	49
Effect of Fat Emulsion and Supersaturation in Parenteral Nutrition Admixtures	Vol. 1 No. 1	54
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets	Vol. 1 No. 1	60
PostScription: The 90s Pharmacist	Vol. 1 No. 1	64
The Decision to Compound	Vol. 1 No. 2	71
The Compounding Pharmacist	Vol. 1 No. 2	73
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies	Vol. 1 No. 2	75
The Mortar and Pestle	Vol. 1 No. 2	80
Compounding for the Pediatric Patient	Vol. 1 No. 2	84
Attention Deficit Hyperactivity Disorder	Vol. 1 No. 2	87
Flavors and Flavoring	Vol. 1 No. 2	90
Compounded Suppositories and Pharmaceutical Care	Vol. 1 No. 2	93
Acetazolamide 25-mg/mL Oral Liquid	Vol. 1 No. 2	101
Azathioprine 50-mg/mL Oral Liquid	Vol. 1 No. 2	102
Flecainide Acetate 20-mg/mL Oral Liquid	Vol. 1 No. 2	103
Methylcellulose 1% to 5% Solutions	Vol. 1 No. 2	104
Methylcellulose Oral-Liquid Vehicles	Vol. 1 No. 2	105
Pediatric Chewable Gummy Gel Base	Vol. 1 No. 2	106
Pediatric Chocolate Troche Base	Vol. 1 No. 2	106
Pediatric Chewable Gummy Gels	Vol. 1 No. 2	107
Pediatric Chocolate Troche	Vol. 1 No. 2	108
Nystatin Popsicles	Vol. 1 No. 2	109
Procainamide HCl 50-mg/mL Oral Liquid	Vol. 1 No. 2	110
Syrup NF	Vol. 1 No. 2	111
Tetracaine 20-mg Lollipops	Vol. 1 No. 2	112
Tetracycline Compound Troche	Vol. 1 No. 2	113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%)	Vol. 1 No. 2	114
Methylcellulose, Featured Excipient:	Vol. 1 No. 2	115
Use, Standardization, Care of a pH Meter	Vol. 1 No. 2	116
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration	Vol. 1 No. 2	118
The Compatibility of Common Respiratory Therapy Drug Combinations	Vol. 1 No. 2	121
Stability of Vancomycin HCl in MEDICATION CASSETTE Reservoirs	Vol. 1 No. 2	123
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture	Vol. 1 No. 2	125
Stability of Allopurinol Suspension Compounded from Tablets	Vol. 1 No. 2	128
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 2	132
PostScription: Growing the Tree of Pharmacy	Vol. 1 No. 2	136
The Changing Body	Vol. 1 No. 3	144
Creative Compounding for the Geriatric Patient	Vol. 1 No. 3	147
Drug Products and Drug Packaging for the Elderly	Vol. 1 No. 3	150
Common Diseases of the Elderly	Vol. 1 No. 3	152
Building a Compounding Lab: Remodeling an Existing Facility or Starting from Scratch?	Vol. 1 No. 3	156
Patient Handouts	Vol. 1 No. 3	160
Computer Technology in the Compounding Pharmacy, The Use of	Vol. 1 No. 3	162
Parenteral Admixture Incompatibilities:An Introduction	Vol. 1 No. 3	165
Physical Stability of Urea Topical Formulations	Vol. 1 No. 3	168
Allopurinol 20-mg/mL Oral Liquid	Vol. 1 No. 3	174
Antiemetic Injection for Cancer Chemotherapy	Vol. 1 No. 3	175
Dipyridamole 10-mg/mL Oral Liquid	Vol. 1 No. 3	176
Dry Skin and Massage Lotion	Vol. 1 No. 3	177
Fentanyl and Bupivacaine Injection for Ambulatory Pump Reservoir	Vol. 1 No. 3	178
Labetalol HCl 40-mg/mL Oral Liquid	Vol. 1 No. 3	179
Metoprolol Tartrate 10-mg/mL Oral Liquid	Vol. 1 No. 3	180
Piroxicam 2% in an Alcoholic Gel	Vol. 1 No. 3	181
Progesterone 100-mg in Peanut-Oil Capsules	Vol. 1 No. 3	182
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid	Vol. 1 No. 3	183
Spironolactone 25-mg/mL Oral Liquid	Vol. 1 No. 3	184
Triple Estrogen 2.5-mg in Oil Capsules	Vol. 1 No. 3	185
Triple Estrogen 2.5-mg in Lactose Capsules	Vol. 1 No. 3	186
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules	Vol. 1 No. 3	187
Verapamil HCl 50-mg/mL Oral Liquid	Vol. 1 No. 3	188
Poloxamer, Featured Excipient:	Vol. 1 No. 3	190
Calculations	Vol. 1 No. 3	191
The Rule of Seven	Vol. 1 No. 3	191
Pipette Calibration	Vol. 1 No. 3	192
The Formulation Development and Stability of Spironolactone Suspension	Vol. 1 No. 3	195
The Formulation Development and Stability of Metronidazole Suspension	Vol. 1 No. 3	200
Metronidazole 15-mg/mL Suspension	Vol. 1 No. 3	202
Stability of Ketorolac Tromethamine in 5% Dextrose Injection and 0.9% Sodium Chloride Injections	Vol. 1 No. 3	206
Stability of Cefmetazole Sodium in 5% dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 3	208
PostScription: Fat Loss: Important in Disease Management	Vol. 1 No. 3	212
What Makes Pharmacists Different?	Vol. 1 No. 4	214
Veterinary Compounding: A Bird's Eye View	Vol. 1 No. 4	222
Suggested Flavors for Veterinary Medications	Vol. 1 No. 4	228
Animal Drug Delivery Systems	Vol. 1 No. 4	229
Compounding for Animals: The AVMA Perspective	Vol. 1 No. 4	230
Symposium on Veterinary Compounding: A Pivotal Meeting	Vol. 1 No. 4	231
Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations	Vol. 1 No. 4	233
Marketing to Veterinarians - Field Notes	Vol. 1 No. 4	236
Compounding for Degenerative Myelopathy in the German Shepherd	Vol. 1 No. 4	241
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease	Vol. 1 No. 4	242
Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary	Vol. 1 No. 4	243
Antique Pill Making Tools	Vol. 1 No. 4	246
Antifungal for Animals	Vol. 1 No. 4	250
Canine Antiperspirant with Chlorhexidine	Vol. 1 No. 4	251
Canine Diarrhea Capsules	Vol. 1 No. 4	252
Canine Eye Ulceration Drops	Vol. 1 No. 4	253
Canine Glucose Enema 60%	Vol. 1 No. 4	254
Canine Methylpyrazole Solution for Ethylene Glycol Poisoning	Vol. 1 No. 4	255
Canine Psyllium Hydrophilic Balls	Vol. 1 No. 4	256
Cyclosporine Ophthalmic Drops for Animals	Vol. 1 No. 4	257
Hair Moisturizer/Conditioner for Horses and Other Animals	Vol. 1 No. 4	258
Kennel Cough Inhalation Solutions (Concentrated)	Vol. 1 No. 4	259
Phenolated Glycerin Otic Solution for Animals	Vol. 1 No. 4	260
Potassium Bromide 500-mg/mL Oral Solution for Animals	Vol. 1 No. 4	261
Silver Sulfadiazine 1% Otic Lotion for Animals	Vol. 1 No. 4	262
Sterile Vehicle for Mastitis Preparation for Animals	Vol. 1 No. 4	263
Sulfur and Peruvian Balsam Ointment for Mange/Ringworm for Animals	Vol. 1 No. 4	264
Carbopols, Featured Excipient:	Vol. 1 No. 4	265
Calculations	Vol. 1 No. 4	267
Monitoring Air Temperature and Humidity	Vol. 1 No. 4	268
Atropine Overdosage with a Suppository Formulation Containing Atropine Sulfate	Vol. 1 No. 4	271
Development of Clonidine HCl Injections for Epidural and Intrathecal Administration	Vol. 1 No. 4	274
Stability of Bethanechol Chloride Oral Liquid Dosage Forms	Vol. 1 No. 4	278
Stability of Ceftriaxone Sodium When Mixed with Metronidazole Injection	Vol. 1 No. 4	280
Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes	Vol. 1 No. 4	282
PostScription: Compounding: Our Heritage	Vol. 1 No. 4	286
Home Infusion and Alternative-Site Health Care: The Big Picture	Vol. 1 No. 5	294
Continued Growth Predicted for Home Infusion Market	Vol. 1 No. 5	298
Drug Stability and Compatibility: Special Considerations for Home Health Care	Vol. 1 No. 5	301
Ambulatory Infusion Pump Review	Vol. 1 No. 5	306
The Future and the Pharmacy Technician	Vol. 1 No. 5	310
Extemporaneous Compounding in the Hospital Pharmacy	Vol. 1 No. 5	314
Acetylcysteine 10% Ophthalmic Solution	Vol. 1 No. 5	320
Baclofen 10-mg/mL Oral Liquid	Vol. 1 No. 5	321
Captopril 0.75-mg/mL Oral Liquid	Vol. 1 No. 5	322
Diltiazem HCl 12-mg/mL Oral Suspension	Vol. 1 No. 5	323
Doxorubicin HCl-Vincristine Sulfate Injection	Vol. 1 No. 5	324
Fentanyl-Bupivacaine-Epinephrine for Epidural Analgesia	Vol. 1 No. 5	325
Granisetron HCl-Dexamethasone Sodium Phosphate Injection	Vol. 1 No. 5	326
Hydromorphone HCl 10-, 25-, and 50-mg/mL Injections	Vol. 1 No. 5	327
Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection	Vol. 1 No. 5	328
Metolazone 1-mg/mL Oral Suspension	Vol. 1 No. 5	329
Morphine Sulfate-Bupivacaine HCl Injection	Vol. 1 No. 5	330
Morphine Sulfate 10-, 25-, and 50-mg/mL Injections (Preservative Free)	Vol. 1 No. 5	331
Ondansetron HCl-Dexamethasone Sodium Phosphate Injection	Vol. 1 No. 5	332
Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection	Vol. 1 No. 5	333
Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations)	Vol. 1 No. 5	334
Tropicamide-Hydroxyamphetamine Hydrobromide Ophthalmic Solution	Vol. 1 No. 5	335
Benzalkonium Chloride, Featured Excipient:	Vol. 1 No. 5	336
Assaying Progesterone in Extemporaneously Prepared Suppositories	Vol. 1 No. 5	339
Paper-Folding Techniques for Compounded, Individualized Powder Dosage Forms	Vol. 1 No. 5	340
Calculations	Vol. 1 No. 5	343
Maintenance of Horizontal Laminar Airflow Hood	Vol. 1 No. 5	344
Chemical Stability of Amiodarone Hydrochloride in Intravenous Fluids	Vol. 1 No. 5	347
Some Quality Control Tests on Chromium Picolinate in Solid Dosage Forms	Vol. 1 No. 5	349
The Stability of Lisinopril as an Extemporaneous Syrup	Vol. 1 No. 5	352
Compatibility of Vancomycin Hydrochloride and Famotidine in 5% Dextrose Injection	Vol. 1 No. 5	354
Compatibility of Warfarin Sodium with Selected Drugs and Large-Volume Parenteral Solutions	Vol. 1 No. 5	356
PostScription: Should Just Any Pharmacist Compound?	Vol. 1 No. 5	362
Ambulatory Care and the Compounding Pharmacist	Vol. 1 No. 6	374
Profile of a Practice - Compounding and Pharmaceutical Care Programs Increase Traffic	Vol. 1 No. 6	376
Ambulatory Care Medicine: Definition and Scope of Service	Vol. 1 No. 6	377
Compounding for Diabetic Patients:An Interview with Paul Lofholm, PharmD	Vol. 1 No. 6	381
Compounding Pharmacists Play a Vital Role in AIDS Treatment	Vol. 1 No. 6	386
Treating Patients with Asthma	Vol. 1 No. 6	389
Antique Suppository Making Tools	Vol. 1 No. 6	392
Basic Statistical Concepts for Evaluating Pharmaceutical Compounding Literature: Part 1.Statistics for Continuous Data and Stability Studies	Vol. 1 No. 6	395
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding	Vol. 1 No. 6	399
Acyclovir Lip Balm	Vol. 1 No. 6	405
Acyclovir Stick with Sunscreen	Vol. 1 No. 6	406
Aspirin in Chloroform (Chloroform Banned in US)	Vol. 1 No. 6	407
Bismuth Iodoform Paraffin Paste (BIPP)	Vol. 1 No. 6	408
Curcumin Ointment	Vol. 1 No. 6	409
Dexamethasone and Lidocaine Solution for Iontophoresis	Vol. 1 No. 6	410
Estriol Solution for Iontophoresis for Acne Scars	Vol. 1 No. 6	411
Fluconazole 200-mg Suppositories	Vol. 1 No. 6	412
Fluconazole 2% Shampoo	Vol. 1 No. 6	413
Ketoconazole 20-mg/mL Oral Liquid	Vol. 1 No. 6	414
Ketorolac Solution for Iontophoresis	Vol. 1 No. 6	415
Lidocaine HCl 2% Solution for Iontophoresis	Vol. 1 No. 6	416
Morphine 10-mg Troches	Vol. 1 No. 6	417
Vancomycin Gel (Vancomycin Paste, Vanc Paste)	Vol. 1 No. 6	418
Wound Care Mixture	Vol. 1 No. 6	419
Iontophoresis Devices: Clinical Applications for Topical Delivery	Vol. 1 No. 6	420
Calculations	Vol. 1 No. 6	425
Water, Featured Excipient:	Vol. 1 No. 6	426
Laudanum and Paregoric: History and Compounding Considerations	Vol. 1 No. 6	428
Origin of Laudanum and Paregoric	Vol. 1 No. 6	428
Cleaning, Inspecting and Flow-Accuracy Testing of Ambulatory Pumps	Vol. 1 No. 6	430
Stability of Two Concentrations of Heparin Sodium Prefilled in CADD-Micro Pump Syringes	Vol. 1 No. 6	433
Stability of Cefepime Hydrochloride Dextrose in 5% Dextrose Injection and 0.9% Sodium Chloride Injection	Vol. 1 No. 6	435
Short-Term Stability of Atenolol in Oral Liquid Formulations	Vol. 1 No. 6	437
Stability of Clonazepam Suspension in HSC Vehicle	Vol. 1 No. 6	440
PostScription: Issues for TPN Pharmacists	Vol. 1 No. 6	444

	Mailed CD